-
Product Insights
Hopkins Ridge
Hopkins Ridge is an Onshore Wind project located in Washington, United States. The project is owned by Puget Sound Energy Inc and was developed by Puget Sound Energy Inc; Renewable Energy Systems Americas Inc. The project came online in 2005. Empower your strategies with our Hopkins Ridge report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Hopkins Solar PV Park
Hopkins Solar PV Park is a solar PV project located in Texas, United States. The project is owned and being developed by Hopkins Energy LLC. The project is at the permitting stage. Empower your strategies with our Hopkins Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Arvah B. Hopkins Unit 2 Repowering Project
Arvah B. Hopkins Unit 2 Repowering Project is a thermal project located in Florida, United States. The project is owned by City of Tallahassee Electric Utility. The project came online in 2008. Empower your strategies with our Arvah B. Hopkins Unit 2 Repowering Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
NewAtherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Atherectomy Devices Pipeline Market Report Overview Atherectomy is a minimally invasive procedure that removes plaque from vessels. Atherectomy is especially valuable in eliminating highly calcified plaque. Atherectomy procedures may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting. Coronary Atherectomy Devices and Lower Extremity Peripheral Atherectomy Devices are covered under this category. One unit refers to a single atherectomy system, without consoles or accessories. The...
-
Sector Analysis
NewRetinitis Pigmentosa (RP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Retinitis Pigmentosa (RP) Marketed and Pipeline Drugs Report Overview Retinitis pigmentosa (RP) is a cluster of rare eye conditions. One of these conditions causes degeneration of the retina, the light-sensitive layer at the back of the eye. This degeneration results in a progressive loss of vision. Retinitis pigmentosa is an inherited genetic disorder. Most people have progressive vision loss over time, with symptoms usually starting in childhood. While there isn't a cure at this time, people can maximize their residual...
-
Product Insights
NewEndotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Endotracheal Tubes Pipeline Market Report Overview Endotracheal tubes are used to maintain an unobstructed passageway especially to deliver oxygen or anesthesia to the lungs during surgery or any airway management procedure. The curved tube is placed through the patient's nose or mouth into the trachea (windpipe). The endotracheal tubes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-2591 in Prader-Willi Syndrome (PWS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-2591 in Prader-Willi Syndrome (PWS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-2591 in Prader-Willi Syndrome (PWS) Drug Details: NNZ-2591 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-2591 in Rett Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-2591 in Rett Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-2591 in Rett Syndrome Drug Details: NNZ-2591 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-2591 in Angelman Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-2591 in Angelman Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-2591 in Angelman Syndrome Drug Details: NNZ-2591 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACP-2591 in Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACP-2591 in Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACP-2591 in Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome) Drug Details:...